MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2016 International Congress

    Vestibular evoked myogenic potentials as biomarkers for non-motor symptoms of Parkinson’s disease

    A. Shalash, D. Hassan (Cairo, Egypt)

    Objective: To explore the relation between the non-motor symptoms (NMS) of PD and the involvement of brainstem through studying VEMPs. Background: Degeneration of several brainstem…
  • 2016 International Congress

    Pallidal versus subthalamic stimulation for PD: Beyond the motor effects

    M.G. dos Santos Ghilardi, R.G. Cury, R.C.R. Martinez, M.J. Teixeira, E.R. Barbosa, E.T. Fonoff (Sao Paulo, Brazil)

    Objective: To evaluate the effects of Deep Brain Stimulation(DBS) on non motor symptoms(NMS) in Parkinson's disease(PD) and compare the efficacy of pallidal(GPi) versus subthalamic(STN) stimulation.…
  • 2016 International Congress

    Irritable bowel syndrome is more prevalent than functional constipation in Parkinson’s disease: Clinical spectrum and changes in gut microbiota

    T. Mertsalmi, V. Aho, P.A.B. Pereira, L. Paulin, E. Pekkonen, P. Auvinen, F. Scheperjans (Helsinki, Finland)

    Objective: To assess distal functional gastrointestinal (GI) symptoms and their connection to fecal microbiota (FM) in Parkinson (PD) patients. Background: The majority of PD patients…
  • 2016 International Congress

    Frequency and factors associated with neuropathic pain in patients with Parkinson’s disease

    J.F. Pascacio-Astudillo, A.L. Bazàn-Rodrìguez, M. Rodrìguez-Violante, A. Cervantes-Arriaga (Mèxico City, Mexico)

    Objective: To determine the prevalence of neuropathic pain in PD and association between neuropathic pain, duration of PD, treatment with Levodopa, cumulative dose, non-motor symptoms…
  • 2016 International Congress

    Behavioral and neuroimaging effects of LSVT-BIG and conventional physiotherapy in Parkinson’s disease

    F. Schaible, F. Schwartz, T. v. Eimeren, C. Eggers (Köln, Germany)

    Objective: To evaluate (1) the changes of non-motor symptoms such as depression, sleep disorders, pain and cognitive deficits in PD by practicing LSVT BIG therapy…
  • « Previous Page
  • 1
  • …
  • 53
  • 54
  • 55

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley